Engaging with Laboratories (Personalized Medicine: What Pharma Should Do to Get Ready)

In part 7 of the series ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses the importance of pharmaceutical companies engaging with laboratories, which are often the forgotten stakeholder.|In part 7 of the series ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses the importance of pharmaceutical companies engaging with laboratories, which are often the forgotten stakeholder.|In part 7 of the series ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses the importance of pharmaceutical companies engaging with laboratories, which are often the forgotten stakeholder.|In part 7 of the series ‘Personalized Medicine: What Pharma Should Do to Get Ready', Tessa Sandberg of Diaceutics discusses the importance of pharmaceutical companies engaging with laboratories, which are often the forgotten stakeholder.